Pricing Divergence Amid Liquidity Shifts: A Microcosm of Cross-Border RisksGlobal Report·Jul 9 at 09:02 PMXYF+0.21%BQ-4.60%
The AI Hustle and Old Economy Debris: What Happens in the Market's Forgotten CornersGlobal Report·Jul 9 at 05:03 AMBTBT-8.67%XYF+0.21%
The 2026 Barbell Market: Value Chain Ascension and the Restructuring TailGlobal Report·Jul 8 at 10:32 PMBAYZF0.00%TRON-5.81%
Bayer Group to Consolidate U.S. Glyphosate Business Into Distinct Entity Operating as Ruveon | BAYRY Stock NewsStockTitan·Jul 1 at 09:33 AMBAYNBAYRY0.00%
Managers' transactions announcement according to article 19 MARpressetext·Jul 1 at 09:35 AMBAYZF0.00%BAYN
Bayer Wins Legal Fight in Bid for $7.25 Billion Roundup Settlement ApprovalCoinLive·Jun 17 at 09:58 PMBAYZF0.00%BAYN
Key facts: Bayer Opposes $7.25B Roundup Transfer; Farm Bill ThreatensTradingView·Jun 3 at 12:13 AMBAYRY0.00%BAYN
Bayer Shares Fall on Renewed Uncertainty Over $7 Billion U.S. SettlementMorningStar·Jun 2 at 06:26 AMBAYZF0.00%BAYRY0.00%
Bayer's Q1 Profit Surpasses Expectations Due to Strong Crop Science PerformanceCoinLive·May 12 at 01:07 AMBAYZF0.00%BAYRY0.00%
<![CDATA[Pharma M&A Roundup: Bayer to Acquire Perfuse Therapeutics, Madrigal Enters Licensing Agreement for ARO-PNPLA3]]>Pharmexec·May 6 at 08:19 AMARWR-1.36%MDGL+0.21%
